Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
BOSTON & PRINCETON, N.J.--(BUSINESS WIRE)--May 29, 2024--
Stay updated with breaking news from Danielle Johns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON & PRINCETON, N.J.--(BUSINESS WIRE)--May 29, 2024--
Definitive Healthcare Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 05, 2023 -- Definitive Healthcare Corp. ; class='js-l-obf link link--blue'
FRAMINGHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence,...
FRAMINGHAM, Mass., Sept. 08, 2023 -- Definitive Healthcare , an industry leader in healthcare commercial intelligence, today announced that in connection with Definitive Healthcare’s acquisition...